PRODUCTS

Nifedipine Sustained-release Tablets(II)

basic information
NO.:
Categories:
products
没有此类产品
I want to inquire
Product description

Name:Nifedipine Sustained-release Tablets(II)

Specification:20mg 

Approval NumberState Drug AdministrationH20234699

 

Indication Chronic stable angina pectoris (fatigue angina pectoris); Angina vasospasm (Prinzmetal's angina, variant angina). Essential hypertension.

· Shijiazhuang No.4 Pharmaceutical CO.,LTD"a continuous refining method of nifedipine" won the national patent

· The finished nifedipine produced by the refining method has average particle size distribution, uniform crystal size, stable product quality and guaranteed quality.

Usage and dosage

Oral. General adults take 20mg orally, twice a day, and adjust according to symptoms.

On a
Tedizolid Phosphate Tablets
The next article
Ropivacaine Hydrochloride and Sodium Chloride Injection